Savior LLC’s Clover Health Investments CLOV Stock Holding History

Savior LLC’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-100	Closed	–	–	165
2021 Q4	$0	Hold	100	–	–	﹤0.01%	182
2021 Q3	$1K	Hold	100	–	–	﹤0.01%	169
2021 Q2	$1K	Buy	+100	New	+$982	﹤0.01%	781

Other funds holding CLOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Savior LLC's CLOV Position: Q1 2022 in Review

Savior LLC sold out of Clover Health Investments (CLOV) in Q1 2022, closing a stake of 100 shares.

Savior LLC first reported a position in CLOV in Q2 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 168 funds tracked by Wall St. Rank hold CLOV as of Q1 2022.

Savior LLC reported no remaining Clover Health Investments position as of Q1 2022 after selling out during the quarter.
Savior LLC sold 100 Clover Health Investments shares in Q1 2022.
Savior LLC first reported a position in Clover Health Investments in Q2 2021 and held it in 3 quarters.
Savior LLC's Clover Health Investments position peaked at $1K in Q3 2021.
168 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2022.

Based on Savior LLC's 13F filing for Q1 2022, filed 12 Apr 2022.